SGIOF
Shionogi & Co., Ltd.
15.21
+0.00+0%
Dec 16, 4:00:00 PM EST

Upcoming Earnings 

Report date
≈ Jan 30, 2026

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
15.48B
P/E (TTM)
11.79
Basic EPS (TTM)
1.29
Dividend Yield
4.34%

About 

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.

CEO
Dr. Isao Teshirogi Ph.D.
IPO
2/28/2018
Website
https://www.shionogi.com
Employees
4,955
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Related Companies  

BIOE
Bio Essence Corp.
0.05+0.00
GSK
GSK plc
48.78-0.46
HYEX
HEALTHY EXTRACTS INC.
1.99-0.22
NIKA
NIKA PHARMACEUTICALS INC.
0.28+0.00
OGI
Organigram Global Inc.
1.96+0.16
RGC
Regencell Bioscience Holdings L
16.70-0.56
SFWJ
Software Effective Solutions Co
0.00-0.00
SNY
Sanofi
47.44-0.38
TAK
Takeda Pharmaceutical Company L
14.53-0.08
ZYBT
Zhengye Biotechnology Holding L
1.86-0.07